EP3062607A1 - Methods of using o-methyltransferase for biosynthetic production of pterostilbene - Google Patents
Methods of using o-methyltransferase for biosynthetic production of pterostilbeneInfo
- Publication number
- EP3062607A1 EP3062607A1 EP14858679.5A EP14858679A EP3062607A1 EP 3062607 A1 EP3062607 A1 EP 3062607A1 EP 14858679 A EP14858679 A EP 14858679A EP 3062607 A1 EP3062607 A1 EP 3062607A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- pterostilbene
- cellular system
- resveratrol
- making
- expressing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/02—Preparation of oxygen-containing organic compounds containing a hydroxy group
- C12P7/22—Preparation of oxygen-containing organic compounds containing a hydroxy group aromatic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/1003—Transferases (2.) transferring one-carbon groups (2.1)
- C12N9/1007—Methyltransferases (general) (2.1.1.)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/1025—Acyltransferases (2.3)
- C12N9/1029—Acyltransferases (2.3) transferring groups other than amino-acyl groups (2.3.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/93—Ligases (6)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y203/00—Acyltransferases (2.3)
- C12Y203/01—Acyltransferases (2.3) transferring groups other than amino-acyl groups (2.3.1)
- C12Y203/01095—Trihydroxystilbene synthase (2.3.1.95)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y602/00—Ligases forming carbon-sulfur bonds (6.2)
- C12Y602/01—Acid-Thiol Ligases (6.2.1)
- C12Y602/01012—4-Coumarate-CoA ligase (6.2.1.12)
Definitions
- This disclosure has applicability in the food, medicinal, and pharmacological industries.
- This disclosure relates generally to methods for the biosynthetic production of pterostilbene utilizing O-methyltransferase (ROMT).
- EMT O-methyltransferase
- Pterostilbene is a stilbenoid chemically related to resveratrol and is found in blueberries and grapes. It belongs to the group of phytoalexins, agents produced by plants to fight infections. Based on animal studies, it is thought to exhibit anti-cancer, anti- hypercholesterolemia, anti-hypertriglyceridemia properties, as well as the ability to fight off and reverse cognitive decline. It is believed that the compound also has anti-diabetic properties, but so far very little has been studied on this issue.
- the disclosure addresses the technical issue of producing pterostilbene in a cellular system, such as yeast or bacteria.
- Applicants have uniquely isolated the genes for 4- coumarate: coenzyme A ligase (4CL), stilbene synthase (STS), and resveratrol O- methyltransferase (ROMT) and expressed them in a cellular system that facilitate the production of pterostilbene.
- This disclosure provides for the industrial production of resveratrol and pterostilbene.
- the present disclosure is a biosynthetic method of making pterostilbene comprising expressing a 4-coumarate:coenzyme A ligase (4CL) in a cellular system, expressing a stilbene synthase (STS) in the cellular system, expressing a resveratrol O-methyltransferase (ROMT) in the cellular system, feeding p-coumaric acid to the cellular system, growing the cellular system in a medium, and thereby, producing pterostilbene.
- 4CL 4-coumarate:coenzyme A ligase
- STS stilbene synthase
- ROMT resveratrol O-methyltransferase
- Another embodiment is a biosynthetic method of making resveratrol comprising expressing a 4-coumarate:coenzyme A ligase (4CL) in a cellular system, expressing a stilbene synthase (STS) in the cellular system, feeding p-coumaric acid to the cellular system, growing the cellular system in a medium, and producing resveratrol.
- 4CL 4-coumarate:coenzyme A ligase
- STS stilbene synthase
- Another embodiment is a biosynthetic method of making pterostilbene comprising expressing a 4-coumarate:coenzyme A ligase (4CL) in a first cellular system, expressing a stilbene synthase (STS) in the first cellular system, feeding p-coumaric acid to the first cellular system, growing the first cellular system in a medium, producing resveratrol, expressing a resveratrol O-methyltransferase (ROMT) in a second cellular system, feeding the produced resveratrol to the second cellular system, growing the second cellular system in a medium, and producing pterostilbene.
- Figure 1 shows the biosynthetic pathway of pterostilbene.
- Figure 2 shows HPLC profiles of three standards (p-coumaric acid, resveratrol and pterostilbene).
- Figure 4 shows HPLC profiles of extracts from E.coli cells expressing ROMT gene.
- FIG. 4CL::STS and ROMT gene show HPLC profiles of extracts from yeast cells expressing 4CL::STS fusion gene.
- Figure 7 shows HPLC profiles of extracts from yeast cells expressing ROMT gene.
- Figure 8 shows HPLC profiles of extracts from yeast cells co-expressing
- Figure 9 shows model of ROMT represented by ribbon. Substrates are represented by stick model in dark gray. Substrate binding residues are represented by stick model in black color. F167A, D174A, W258A, H261A (H261 is key amino acid) are changes made. They are all key amino acids for activity with H261 being the most important.
- Figure 10 shows HPLC profiles of extracts from E.coli cells expressing wild-type
- Cellular system is any cells that provide for the expression of ectopic proteins. It included bacteria, yeast, plant cells and animal cells. It includes both prokaryotic and eukaryotic cells. It also includes the in vitro expression of proteins based on cellular components, such as ribosomes.
- transfection is more often used to describe non-viral DNA transfer in bacteria, non-animal eukaryotic cells, including plant cells. In animal cells, transfection is the preferred term as transformation is also used to refer to progression to a cancerous state (carcinogenesis) in these cells. Transduction is often used to describe virus-mediated DNA transfer. Transformation, transduction, and viral infection are included under the definition of transfection for this application. Modified Amino Acid
- the 4-coumarate coenzyme A ligase is expressed from a gene that has a sequence identity of at least 66% with a 4CL gene cloned from Arabidopsis thaliana (ecotype Columbia-0).
- the 4- coumarate: coenzyme A ligase is expressed from a gene that has a sequence similarity of at least 90% with a 4CL gene cloned from Arabidopsis thaliana (ecotype Columbia-0).
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Hospice & Palliative Care (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Psychiatry (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Enzymes And Modification Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Description
Claims
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361898899P | 2013-11-01 | 2013-11-01 | |
| PCT/US2014/063682 WO2015066609A1 (en) | 2013-11-01 | 2014-11-03 | Methods of using o-methyltransferase for biosynthetic production of pterostilbene |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| EP3062607A1 true EP3062607A1 (en) | 2016-09-07 |
| EP3062607A4 EP3062607A4 (en) | 2017-03-22 |
| EP3062607B1 EP3062607B1 (en) | 2019-06-26 |
Family
ID=53005254
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP14858679.5A Active EP3062607B1 (en) | 2013-11-01 | 2014-11-03 | Methods of using o-methyltransferase for biosynthetic production of pterostilbene |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US10370683B2 (en) |
| EP (1) | EP3062607B1 (en) |
| JP (1) | JP6522640B2 (en) |
| KR (1) | KR102350425B1 (en) |
| CN (1) | CN106102454B (en) |
| BR (1) | BR112016009734A2 (en) |
| CA (1) | CA2963219C (en) |
| DK (1) | DK3062607T3 (en) |
| ES (1) | ES2745092T3 (en) |
| HU (1) | HUE045463T2 (en) |
| MX (1) | MX369206B (en) |
| WO (1) | WO2015066609A1 (en) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102018422B1 (en) * | 2017-05-31 | 2019-09-04 | 이화여자대학교 산학협력단 | Recombinant vector, transformant and method for producing pterostilbene using the same |
| US20220064092A1 (en) * | 2019-01-21 | 2022-03-03 | Food For Future S.R.L. Società Benefit | Methylation process |
| CN110804618B (en) * | 2019-11-25 | 2022-11-11 | 东北电力大学 | Directed evolution construction of ROMT mutant for efficiently converting resveratrol to produce pinqi |
| CN112410356B (en) * | 2020-11-10 | 2023-07-18 | 杭州鑫旺途科技有限公司 | Resveratrol synthase gene RS derived from Clover and its application |
| CN114807183B (en) * | 2021-12-06 | 2023-06-02 | 西藏自治区农牧科学院农业研究所 | New use of highland barley cyanidin oxymethyl transferase gene |
| CN118773236B (en) * | 2024-06-13 | 2025-06-03 | 谷雨生物科技集团股份有限公司 | A technology for bioconverting resveratrol into pterostilbene using Yarrowia lipolytica |
| CN118652925B (en) * | 2024-06-25 | 2025-02-14 | 广州青囊生物科技有限公司 | An engineered Yarrowia lipolytica strain for synthesizing pterostilbene and its construction method and application |
| CN121555522B (en) * | 2026-01-22 | 2026-04-24 | 崖州湾国家实验室 | Breeding method for synthesizing resveratrol and pterostilbene in endosperm of rice seeds |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5689046A (en) * | 1987-09-30 | 1997-11-18 | Bayer Aktiengesellschaft | Stilbene synthase gene |
| GB0503657D0 (en) * | 2005-02-22 | 2005-03-30 | Fluxome Sciences As | Metabolically engineered cells for the production of resveratrol or an oligomeric or glycosidically-bound derivative thereof |
| GB0614442D0 (en) | 2006-07-20 | 2006-08-30 | Fluxome Sciences As | Metabolically engineered cells for the production of pinosylvin |
| GB0806592D0 (en) * | 2008-04-11 | 2008-05-14 | Fluxome Sciences As | Conversion of stilbenoids |
| CN102120996A (en) * | 2010-12-03 | 2011-07-13 | 西北农林科技大学 | Method for generating pterostilbene by utilizing grape resveratrol-oxygen-methyl transferase to catalyze resveratrol |
| KR101520912B1 (en) * | 2012-09-26 | 2015-05-18 | 한국생명공학연구원 | Method for increasing stilbene content and changing flower color in plant using ROMT and STS gene |
| US20160215306A1 (en) * | 2013-08-30 | 2016-07-28 | Evolva Sa | Method for producing modified resveratrol |
| CN103773704B (en) * | 2013-12-25 | 2015-10-28 | 无锡新和源发酵技术研究院有限公司 | A kind of method utilizing O-methyltransgerase biosynthesizing red sandalwood celery |
-
2014
- 2014-11-03 US US15/033,705 patent/US10370683B2/en active Active
- 2014-11-03 ES ES14858679T patent/ES2745092T3/en active Active
- 2014-11-03 CN CN201480072144.6A patent/CN106102454B/en active Active
- 2014-11-03 WO PCT/US2014/063682 patent/WO2015066609A1/en not_active Ceased
- 2014-11-03 KR KR1020167014617A patent/KR102350425B1/en active Active
- 2014-11-03 DK DK14858679.5T patent/DK3062607T3/en active
- 2014-11-03 MX MX2016005717A patent/MX369206B/en active IP Right Grant
- 2014-11-03 HU HUE14858679A patent/HUE045463T2/en unknown
- 2014-11-03 CA CA2963219A patent/CA2963219C/en active Active
- 2014-11-03 JP JP2016552436A patent/JP6522640B2/en active Active
- 2014-11-03 BR BR112016009734A patent/BR112016009734A2/en not_active Application Discontinuation
- 2014-11-03 EP EP14858679.5A patent/EP3062607B1/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| JP2017502685A (en) | 2017-01-26 |
| HUE045463T2 (en) | 2019-12-30 |
| CA2963219A1 (en) | 2015-05-07 |
| JP6522640B2 (en) | 2019-05-29 |
| CN106102454A (en) | 2016-11-09 |
| CA2963219C (en) | 2022-11-15 |
| BR112016009734A2 (en) | 2017-09-12 |
| CN106102454B (en) | 2020-07-31 |
| WO2015066609A1 (en) | 2015-05-07 |
| MX2016005717A (en) | 2017-02-08 |
| DK3062607T3 (en) | 2019-09-23 |
| US10370683B2 (en) | 2019-08-06 |
| KR20160079865A (en) | 2016-07-06 |
| MX369206B (en) | 2019-10-31 |
| KR102350425B1 (en) | 2022-01-11 |
| EP3062607A4 (en) | 2017-03-22 |
| EP3062607B1 (en) | 2019-06-26 |
| US20160273006A1 (en) | 2016-09-22 |
| ES2745092T3 (en) | 2020-02-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US10370683B2 (en) | Methods of using O-methyltransferase for biosynthetic production of pterostilbene | |
| US11326173B2 (en) | Method of fermentative alpha-ionone production | |
| CN115552010A (en) | Genetically modified yeast for production of cannabigerolic acid, cannabichromenic acid and related cannabinoids | |
| EP4095145A1 (en) | New carbon glycoside glycosyltransferase and use thereof | |
| CN107099559B (en) | Method for biotechnologically producing methylated cinnamic acid and cinnamic acid esters, methylated phenethylamines and coupling products thereof, in particular coupling products of cinnamic acid amides | |
| US20230105024A1 (en) | Bifunctional C-Glycoside Glycosyltransferases and Application Thereof | |
| EP3050971B1 (en) | Process for the enzymatic production of a 4-O-methylated cinnamic acid amide | |
| WO2014170460A2 (en) | Method for the production of collagen proteins derived from marine sponges and an organism able to produce said proteins | |
| JP7387194B2 (en) | Biosynthesis of vanillin from isoeugenol | |
| US12415992B2 (en) | Dioxygenase mutants and use thereof in synthesizing (2S,3R)-3-hydroxypipecolic acid | |
| CN120817879A (en) | A method for extracting retinol from yeast fermentation broth | |
| CN116855467A (en) | A chemical-enzyme coupling method for the synthesis of ergothioneine | |
| CN101928719A (en) | T vector for screening protein soluble expression and its construction method and application | |
| CN115612691B (en) | A method for synthesizing L-theanine in non-tea plants | |
| JP6517644B2 (en) | Shobunol synthetase, polypeptide, gene, and recombinant cell | |
| CN114277024B (en) | A new type of triterpene synthase and its application | |
| HK1230024A1 (en) | Methods of using o-methyltransferase for biosynthetic production of pterostilbene | |
| HK1230024B (en) | Methods of using o-methyltransferase for biosynthetic production of pterostilbene | |
| KR101581185B1 (en) | Method for mass production of quercetin-3-O-galactoside using PeF3GalGT gene in Escherichia coli | |
| CN113564195B (en) | Fructosamine descarbohydrase pichia pastoris expression vector, genetically engineered bacterium, construction method and protein expression method | |
| CN120210138A (en) | 2-Oxoglutarate-dependent dioxygenase 2-ODD from Glycyrrhiza glabra and its encoding gene and application | |
| JP2017012011A (en) | Method for methylating isopentenyl diphosphate and method for producing methylated isopentenyl diphosphate | |
| WO2022102595A1 (en) | Transformant and method for producing carotenoid composition using same | |
| CN113755464A (en) | A LrUGT2 protein involved in the biosynthesis of cinnamonoside B and verbasin and its encoding gene and application | |
| CN120519359A (en) | A recombinant Escherichia coli producing astaxanthin and a method for synthesizing astaxanthin |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| 17P | Request for examination filed |
Effective date: 20160429 |
|
| AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
| AX | Request for extension of the european patent |
Extension state: BA ME |
|
| DAX | Request for extension of the european patent (deleted) | ||
| A4 | Supplementary search report drawn up and despatched |
Effective date: 20170222 |
|
| RIC1 | Information provided on ipc code assigned before grant |
Ipc: A01H 9/00 20060101AFI20170216BHEP Ipc: C12N 9/10 20060101ALN20170216BHEP Ipc: C12N 5/04 20060101ALI20170216BHEP Ipc: C12N 15/52 20060101ALI20170216BHEP Ipc: C12N 9/00 20060101ALN20170216BHEP Ipc: A01H 11/00 20060101ALI20170216BHEP Ipc: C12P 7/22 20060101ALN20170216BHEP |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: EXAMINATION IS IN PROGRESS |
|
| 17Q | First examination report despatched |
Effective date: 20171010 |
|
| RIC1 | Information provided on ipc code assigned before grant |
Ipc: C12N 9/00 20060101ALN20181121BHEP Ipc: C12N 5/04 20060101ALI20181121BHEP Ipc: C12N 15/52 20060101ALI20181121BHEP Ipc: C12N 9/10 20060101ALN20181121BHEP Ipc: A01H 9/00 20060101AFI20181121BHEP Ipc: A01H 11/00 20060101ALI20181121BHEP Ipc: C12P 7/22 20060101ALN20181121BHEP |
|
| GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: GRANT OF PATENT IS INTENDED |
|
| INTG | Intention to grant announced |
Effective date: 20190108 |
|
| GRAS | Grant fee paid |
Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
|
| GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE PATENT HAS BEEN GRANTED |
|
| AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
| REG | Reference to a national code |
Ref country code: GB Ref legal event code: FG4D |
|
| REG | Reference to a national code |
Ref country code: CH Ref legal event code: EP |
|
| REG | Reference to a national code |
Ref country code: AT Ref legal event code: REF Ref document number: 1147228 Country of ref document: AT Kind code of ref document: T Effective date: 20190715 |
|
| REG | Reference to a national code |
Ref country code: DE Ref legal event code: R096 Ref document number: 602014049245 Country of ref document: DE |
|
| REG | Reference to a national code |
Ref country code: IE Ref legal event code: FG4D |
|
| REG | Reference to a national code |
Ref country code: DK Ref legal event code: T3 Effective date: 20190919 |
|
| REG | Reference to a national code |
Ref country code: SE Ref legal event code: TRGR |
|
| REG | Reference to a national code |
Ref country code: NL Ref legal event code: MP Effective date: 20190626 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: AL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190626 Ref country code: LT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190626 Ref country code: HR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190626 Ref country code: NO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190926 Ref country code: FI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190626 |
|
| REG | Reference to a national code |
Ref country code: LT Ref legal event code: MG4D |
|
| REG | Reference to a national code |
Ref country code: DE Ref legal event code: R082 Ref document number: 602014049245 Country of ref document: DE Representative=s name: ZWICKER SCHNAPPAUF & PARTNER PATENTANWAELTE PA, DE |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190927 Ref country code: BG Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190926 Ref country code: RS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190626 Ref country code: LV Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190626 |
|
| REG | Reference to a national code |
Ref country code: HU Ref legal event code: AG4A Ref document number: E045463 Country of ref document: HU |
|
| REG | Reference to a national code |
Ref country code: AT Ref legal event code: MK05 Ref document number: 1147228 Country of ref document: AT Kind code of ref document: T Effective date: 20190626 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: AT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190626 Ref country code: EE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190626 Ref country code: NL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190626 Ref country code: PT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20191028 Ref country code: SK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190626 Ref country code: CZ Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190626 Ref country code: RO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190626 |
|
| REG | Reference to a national code |
Ref country code: ES Ref legal event code: FG2A Ref document number: 2745092 Country of ref document: ES Kind code of ref document: T3 Effective date: 20200227 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20191026 Ref country code: SM Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190626 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: TR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190626 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: PL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190626 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20200224 |
|
| REG | Reference to a national code |
Ref country code: DE Ref legal event code: R097 Ref document number: 602014049245 Country of ref document: DE |
|
| PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
| PG2D | Information on lapse in contracting state deleted |
Ref country code: IS |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20191103 Ref country code: MC Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190626 |
|
| 26N | No opposition filed |
Effective date: 20200603 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190626 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: CY Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190626 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190626 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20190626 |
|
| PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: HU Payment date: 20241122 Year of fee payment: 11 |
|
| PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: DE Payment date: 20241121 Year of fee payment: 11 |
|
| PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: DK Payment date: 20241125 Year of fee payment: 11 |
|
| PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: BE Payment date: 20241120 Year of fee payment: 11 |
|
| PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: GB Payment date: 20241120 Year of fee payment: 11 |
|
| PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: FR Payment date: 20241128 Year of fee payment: 11 |
|
| PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: IT Payment date: 20241126 Year of fee payment: 11 Ref country code: ES Payment date: 20241230 Year of fee payment: 11 |
|
| PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: SE Payment date: 20241120 Year of fee payment: 11 |
|
| PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: CH Payment date: 20241201 Year of fee payment: 11 |
|
| PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: IE Payment date: 20260203 Year of fee payment: 12 |
|
| REG | Reference to a national code |
Ref country code: DE Ref legal event code: R119 Ref document number: 602014049245 Country of ref document: DE |
|
| REG | Reference to a national code |
Ref country code: DK Ref legal event code: EBP Effective date: 20251130 |
|
| REG | Reference to a national code |
Ref country code: CH Ref legal event code: H13 Free format text: ST27 STATUS EVENT CODE: U-0-0-H10-H13 (AS PROVIDED BY THE NATIONAL OFFICE) Effective date: 20260623 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20251104 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: CH Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20251130 Ref country code: HU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20251104 |